Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions-Reference-Cited by-同舟云学术

Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions

Published:2023-06-01 Issue:7 Volume:62 Page:1031-1041
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Cattani Vitória Berg^ORCID,Jalil Emilia Moreira^ORCID,Eksterman Leonardo,Torres Thiago^ORCID,Wagner Cardoso Sandra^ORCID,Castro Cristiane R. V.^ORCID,Monteiro Laylla^ORCID,Wilson Erin^ORCID,Bushman Lane,Anderson Peter^ORCID,Veloso Valdilea Gonçalves^ORCID,Grinsztejn Beatriz^ORCID,Estrela Rita^ORCID,Hoagland Brenda,Moura Isabele,Waite Daniel M. McMahon,Vieira Desirée,Granjeiro José Roberto,Freitas Josias,Santos Toni,Fernandes Nilo,Nazer Sandro,Marins Luana M. S.,Ribeiro Valéria R. T.,Silva Robson P. N.,Costa Giovanna G.,Vieira Ana Carolina,Bastos Renata A,Alves Aline,Krstic Tania,Ferreira Ana Cristina G.,Derrico Monica,Kamel Luciana,Jalil Cristina M.,Netto Eduardo Carvalheira,de Sousa Marcos Davi G.,Leite Pedro,Mattos Kim Geraldo,Felix Jessica Bezerra,Baião Tamires Vilela,Hottz Gisele,Maia Natália Gomes,da Silva Tamiris Paixão,Ramos Michelle,Porto Tiago,

Funder

Brazilian Ministry of Health

Secretaria de Vigilância em Saúde

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-023-01248-0.pdf

Reference39 articles.

1. Stutterheim SE, van Dijk M, Wang H, et al. The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis. PLoS ONE. 2021;16(12): e0260063. https://doi.org/10.1371/journal.pone.0260063.

2. Grinsztejn B, Jalil EM, Monteiro L, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4:e169–76. https://doi.org/10.1016/S2352-3018(17)30015-2.

3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99. https://doi.org/10.1056/NEJMoa1011205.

4. Ministerio da Saude. Secretaria de Vigilancia em Saude. Protocolo Clínico e Diretrizes Terapêuticas para Profilaxia Pré-Exposição (PrEP) de risco à infecção pelo HIV. Nov 23 2018. http://www.aids.gov.br/system/tdf/pub/2016/64510/miolo_pcdt_prep_11_2018_web.pdf?file=1&type=node&id=64510&force=1. Accessed 25 Nov 2018.

5. Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016;19(6):21105. https://doi.org/10.7448/IAS.19.7.21105.